Please refer to the Patient Information Leaflet (PIL) found in the product carton for a full list of side effects, warnings and precautions.
On this page, you can find important information about ‘warnings and precautions’ and ‘side effects’ for Wegovy®.
You’ll also be able to find some ‘tips for managing nausea’ (feeling sick), which is a very common side effect of Wegovy®.
Talk to your doctor, pharmacist or nurse before using Wegovy® or during treatment if you have:
Wegovy® contains:
Do not use Wegovy® if you are allergic to semaglutide or any of the other ingredients listed above. See the Wegovy® Patient Information Leaflet (PIL), which comes with your pen, for more information.
Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines.
You should not use this medicine if you are breast-feeding, as it is not known if it passes into breast milk.
Wegovy® is unlikely to affect your ability to drive and use machines. Some people may feel dizzy when taking Wegovy® mainly during the first three months of treatment. If you feel dizzy you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist or nurse.
Tell your healthcare team if you have diabetes. Your doctor may adjust the dose of your diabetes medicines to prevent you from getting low blood sugar.
Using Wegovy® in combination with a sulfonylurea or insulin can cause low blood sugar. Low blood sugar can reduce your ability to concentrate. Do not drive or use machines if you get any signs of low blood sugar. See the ‘low blood sugar’ section above for more information on the warning signs of low blood sugar.
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially ‘sodium-free’.
Please tell your doctor that you are taking Wegovy® if you are due to have surgery where you will be under anaesthesia (sleeping).
Like all medicines, Wegovy® can cause side effects, although not everybody gets them.
Very common of Wegovy®: may affect more than 1 in 10 people
These usually go away over time.
Common of Wegovy®: may affect up to 1 in 10 people
For a full list of side effects, please refer to the Patient Information Leaflet (PIL).
Feeling nauseous (sick) is a very common side effect of Wegovy®. You should speak to your healthcare team if you are struggling with nausea.
You can also try the following tips:
Distracting yourself with something you enjoy can help manage nausea, such as watching a film or listening to a podcast.
Getting fresh air by opening a window or spending time outside can help manage nausea.
may affect up to 1 in 10 people
may affect up to 1 in 100 people
may affect up to 1 in 1,000 people
this means there is not enough data to determine how common this side effect is
The information on this website does not replace the Patient Information Leaflet (PIL), which you are advised to read in full. It is not intended as a substitute for clinical advice provided by your healthcare professional. Please contact your healthcare professional if you have any questions about your treatment and for clinical advice. Please refer to the PIL found in the product carton for further information on Wegovy®, further information on how to use Wegovy® and a full list of side effects, warnings and precautions.
This medicine is subject to additional
monitoring. This will allow quick identification of new safety
information promptly. You can help by reporting any side effects you
may get. See https://yellowcard.mhra.gov.uk/ for how to report
side effects.
If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes any possible side effects
not listed in the package leaflet. You can also report side effects
directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. Side effects
should also be reported to Novo Nordisk Limited (Telephone Novo
Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored
for training purposes. By reporting side effects, you can help provide
more information on the safety of this medicine.